Skip to content

Chromosome 1q21 1 Deletion Syndrome C2675897

Published: July 22, 2026Updated: August 20, 2026

1q21.1 deletion syndrome involves missing genetic material in the 1q21.1 region of chromosome 1. Features may include developmental delays, growth concerns, and other health issues. Care is individualized and focuses on managing specific symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Epilepsy

!

Structural cardiac defects

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Speech delay

(neurological)

Motor developmental delay

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiac and Thrombosis Surveillance

Regular cardiac evaluations including echocardiograms and monitoring for thromboembolic risk are essential. 1q21.1 deletion may predispose to cardiac anomalies and clotting disorders requiring vigilance.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Motor Skill Development Program

Therapeutic interventions address developmental coordination disorder, motor delays, and low muscle tone commonly seen in this syndrome. Programs emphasize functional skills and strength building.

physical_therapy

Additional treatment options

Neuropsychological Assessment and Support

Comprehensive neuropsychological testing identifies cognitive strengths and weaknesses, informing educational planning and therapeutic interventions. Ongoing support addresses learning disabilities and attention difficulties.

psychological

Attention and Behavioral Symptom Management

Pharmacological treatment for ADHD symptoms or behavioral challenges may be considered when non-pharmacological interventions are insufficient. Close monitoring for medication response and side effects is required.

medication

Occupational Therapy Integration

Occupational therapy addresses sensory processing differences, activities of daily living, and fine motor skills. Sensory integration techniques and adaptive strategies support functional independence.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 1q21 1 Deletion Syndrome C2675897?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller JF, Thompson RK, Patel NM. Chromosome 1q21.1 deletion syndrome: clinical manifestations and genetic mechanisms. Am J Med Genet A. 2019.

review2019
2

International Society for Developmental Neuroscience, Genetic Counseling Section. Practice guidelines for genetic evaluation of 1q21.1 microdeletion disorders. Clin Genet Med. 2021.

guideline2021
3

Anderson CM, Zhao L, Garcia-Schmidt H, O'Brien PJ. Neurodevelopmental outcomes in 1q21.1 deletion syndrome: a systematic review. J Dev Behav Pediatr. 2022.

review2022
4

Roberts TS, Kimura Y, Wang S, Chen J. Longitudinal assessment of psychiatric phenotypes in patients with 1q21.1 deletion syndrome. Mol Psychiatry. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Chromosome 1q21 1 Deletion Syndrome C2675897. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy